-
I can’t keep up this exhausting pace as a mom, teacher, and caregiver
I am going at a pace I can’t maintain. As a former half-marathon runner, I […]
-
Share your NOW: The impact of up-to-date data in The Duchenne Registry
The Duchenne Registry is designed as a longitudinal (long-term) research study, collecting information from the […]
-
Fire Fighters Go the Distance for MDA
Thomas Beers knew from a very young age that he wanted to be a fire […]
-
Now measuring my life in pounds, ounces, minutes, and seconds
In a recent column, I talked about paring down my music rig and retiring my […]
-
MDA Ambassador Guest Blog: What I’ve Learned as a Disability and Wellbeing Researcher
Payton Rule is a Clinical Psychology PhD student at Washington University in St. Louis, where […]
-
Myotonic dystrophy patients in US face higher healthcare costs: Study
People with myotonic dystrophy (DM) use more healthcare resources and face higher associated costs than […]
-
Duvyzat recommended for EU approval as DMD treatment
The Committee for Medicinal Products for Human Use, an arm of the European Medicines Agency […]
-
Watch: Sarepta Therapeutics – Duchenne Gene Therapy Update (Webinar Recording)
Sarepta Therapeutics recently joined PPMD for a community webinar to share the latest updates on […]
-
The BELS Questionnaire: A New Tool to Support Your Child’s Emotional Wellbeing
PPMD is excited to share that a new tool, the BELS (Behavioral, Emotional, Learning, and […]
-
Simply Stated: Updates in Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a rare, progressive neurodegenerative disease that leads to muscle weakness, […]
